But no other patients stopped taking the drug due to adverse events across any of the different dosing groups, Amgen Chief Medical Officer Paul Burton said during a conference earlier this month
Clinical trials are testing a 25 mg dose, which has shown weight loss results comparable to the highest dose of Wegovy, its injectable counterpart for weight loss
GLP-1 medications carry serious gastroparesis risks that extend far beyond commonly reported nausea and vomiting, requiring heightened clinical awareness and proactive management strategies
J Biol Inorg Chem
Imcivree is indicated for adults and children aged 6 and older with specific genetic deficiencies, while Wegovy is approved for adults and children aged 12 and older with obesity (BMI 30 or BMI 27 with health issues)
Instead, there are a handful of evidence-based nutritional principles that help you get the most from GLP-1 medications while supporting healthy, sustainable weight loss